Mr. Shane Madden reports

HYDREIGHT ANNOUNCES $10 MILLION BOUGHT DEAL PRIVATE PLACEMENT

Hydreight Technologies Inc. has entered into an agreement with Canaccord Genuity Corp. as lead underwriter and sole bookrunner and a syndicate of underwriters to be formed pursuant to which the company has launched a bought deal private placement of 2.47 million units of the company at a price of $4.05 per unit for aggregate gross proceeds of $10,003,500.

Shane Madden, the chief executive officer of the company, commented: "Q4 demonstrated the continued and accelerating strength of our model -- expanding proven pharmacy product lines and launching high-demand products drives real, scalable growth. This financing will allow us to further accelerate that momentum and expedite customer growth on all three verticals by expanding our technology and platform offerings, expanding production capacity, accelerating new product rollouts, and strengthening the infrastructure needed to support growing demand across our nationwide platform."

Each unit will consist of one common share of the company and one-half of one common share purchase warrant of the company. Each warrant will entitle the holder thereof to purchase one common share at a price of $5.27 at any time on or before the date which is 24 months after the closing date of the offering.

The company will grant to the underwriters an option, exercisable up to 48 hours prior to the closing date, to purchase for resale up to an additional 50 per cent of the units issued under the underwritten offering at the issue price for additional gross proceeds of up to $5,001,750. The units being offered pursuant to the underwritten offering, including the additional units that may be issued on exercise of the underwriters' option, shall be collectively referred to hereinafter as the offered securities.

The net proceeds of the sale of the offered securities will be used to support sales growth, to create new and expand existing pharmacy production lines, and for working capital and general corporate purposes, as more specifically described in the offering document.

The offering will be completed on a private placement basis: (i) in reliance on the listed issuer financing exemption from the prospectus requirements available under Part 5A.2 of National Instrument 45-106 (Prospectus Exemptions), as modified by Coordinated Blanket Order 45-935 (Exemptions from Certain Conditions of the Listed Issuer Financing Exemption) in each of the provinces and territories of Canada; (ii) in the United States and to, or for the account or benefit of, U.S. persons pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended; and (iii) in such other jurisdictions other than Canada and the United States pursuant to relevant prospectus or registration exemptions in accordance with applicable laws, provided that no prospectus filing or comparable obligation, continuing reporting or continuous disclosure requirement, or requisite regulatory or governmental approval arises in such jurisdictions.

There is an offering document related to the offering that can be accessed under the company's profile on SEDAR+ and on the company's website. Prospective investors should read this offering document before making an investment decision.

The company has agreed to: (i) pay the underwriters a cash commission equal to 6.0 per cent of the aggregate gross proceeds raised under the offering; and (ii) issue to the underwriters warrants, exercisable at any time prior to the date that is 24 months from the closing date, to acquire that number of common shares equal to 6.0 per cent of the number of units sold under the offering at an exercise price equal to the issue price.

The offering is expected to close on or about Jan. 27, 2026, and is subject to the company receiving all necessary regulatory approvals, including the approval of the TSX Venture Exchange.

About Hydreight Technologies Inc.

Hydreight is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2,500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enable licensed health care professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, medspa technicians and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states, and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

We seek Safe Harbor.